Dr. Kaveh Alizadeh is an innovator and a mentor on the leading edge of medicine. He is a pioneer vs. a settler and believes that you have to be in it and evaluate it before you embrace it. He is inspired by science and driven by knowledge. Through complex research projects and a dynamic educational style, Dr. Alizadeh is part of an academic and clinical movement that is changing the world.
Dr. Alizadeh continues to develop a new paradigm for teaching wherever he goes, most recently introducing new educational systems in the developing world by leveraging technology. Whether he is participating in national trials that test groundbreaking technologies in breast reconstruction, introducing new techniques that lead to long-lasting form for the body, or designing the novel use of injectables for the face, Dr. Alizadeh is changing the conversation about global health and more importantly your individual longevity and health.
Dr. Alizadeh has always been on the cutting edge of medicine, leading clinical studies and training students and doctors in the most innovative new procedures and treatments. Dr. Alizadeh participates in major national clinical trials that bring together the latest technology and tools to patients in the United States and has pioneered procedures that provide rapid recovery and long-lasting results with minimally invasive techniques for patients.
Click here to access Dr. Alizadeh's biography and curriculum vitae.
Board-certified plastic surgeon Dr. Kaveh Alizadeh actively participates in ongoing research and clinical trials to advance the safety and efficacy of technologies and techniques in the field of plastic and reconstructive surgery. Clinical trials help researchers and clinicians improve medicine in the following ways:
Dr. Alizadeh's ongoing research focuses on regenerative medicine, including acellular dermal matrices and bioengineered tissue-scaffolding materials, new-generation breast implants, novel breast reconstruction tissue expanders, pharmaceutical approaches to localized fat reduction, improved body-contouring technologies, and autologous fat grafting.
Contact Cosmoplastic Surgery to discover how to participate in ongoing research and clinical trials. Email our office, or phone 212.348.0100 (Manhattan) / 516.439.5010 (Long Island).
Application of Clozex wound closure device for Pediatric Population: A Prospective, Randomized, controlled single blind comparative study. (ongoing since Spring 2019)
Objective: Measure the objective quality and cost of wound closure comparing Clozex with traditional sutures or skin glue techniques in the pediatric population.
Research Question/ Hypothesis: Clozex is a safe and effective wound closure technique that can lower cost and closure time of pediatric traumatic lacerations.
Phase III: Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study
The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery
Breast Reconstruction Phase II: AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Breast Reconstruction Feasibility Trial
Post Approval Study: Silicone Breast Implants
Breast Scar Study: PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
Phase IV: Evaluation of Radiesse® Dermal Filler for Hand Rejuvenation
Evaluation injectable for removal of fat.
Read published contributions Dr. Alizadeh recently authored.
Contact Us
646-665-1915